Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg®) in children with relapsed/refractory myeloid leukemia
Benoit Brethon, Anne Auvrignon, Claire Galambrun, Karima Yakouben, Thierry Leblanc, Yves Bertrand, Guy Leverger, André BaruchelVolume:
6
Language:
english
DOI:
10.1186/1471-2407-6-172
Date:
December, 2006
File:
PDF, 259 KB
english, 2006